Crispr Therapeutics shares owned by Bridgefront Capital
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Bridgefront Capital
from 13F filings
Historical chart of Bridgefront Capital investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Bridgefront Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Bridgefront Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $243k | 4.5k | 54.01 |
| 2023-12-31 | $258k | 4.1k | 62.60 |
| 2023-06-30 | $302k | 5.4k | 56.14 |